Overview

Use of Modafinil in the Treatment of Tinnitus

Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
A study on the effects of the FDA approved drug Modafinil upon attention problems associated with tinnitus. This is considered to be a safe drug with few side effects. Each subject will be asked to participate in 3 sessions each lasting approximately 1 hour in which cognitive testing and recordings will be taken. The study involves each subject taking a 2- week supply of Modafinil and a 2- week supply of placebo. We hypothesize inattention related to thalamocortical dysrhythmia found in tinnitus can be reduced by Modafinil thus improving vigilance.
Phase:
Phase 1
Details
Lead Sponsor:
University of Arkansas
Treatments:
Armodafinil
Modafinil